Related Experiment Video
Updated: Jun 21, 2026

Production of Nanofibrillar Patterned Collagen for Tissue Engineering
Published on: September 20, 2024
Collagen cross-linkage: a comprehensive review and directions for future research
1Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QH, UK. pammal.ashwin@gmail.com
Abstract:
Individuals with keratoconus form a significant proportion of patients for a practitioner specialising in corneal diseases. Yet it is a disease where the pathogenesis is poorly understood, and until recently, there has been no treatment apart from transplantation that could be offered that was curative or even capable of slowing the progression of the disease. Collagen cross-linking treatment using riboflavin and UV light has been developed to address this need, and the initial results are promising. The purpose of this review is to critically evaluate this treatment in light of the scientific basis for cross-linking, to highlight the strengths and limitations of the evidence in terms of efficacy and long-term safety, and finally to identify areas for future research in this area with a significant potential to change the way we treat our keratoconus patients. In addition, we hope that our unbiased review for the first time would bring together, in a concise fashion, scientific information for a practitioner contemplating on offering this treatment and to help inform their patients of its potential risks and benefits.
Insights
Collagen cross-linking is a promising new treatment for keratoconus, a progressive eye disease. This therapy uses riboflavin and UV light to strengthen the cornea, potentially slowing disease progression and improving patient outcomes.
Area of Science:
- Ophthalmology
- Corneal Diseases
- Biomedical Engineering
Background:
- Keratoconus is a poorly understood corneal disease with limited treatment options.
- Currently, corneal transplantation is the only curative option for advanced keratoconus.
- There is a need for treatments that can slow or halt keratoconus progression.
Purpose of the Study:
- To critically evaluate collagen cross-linking as a treatment for keratoconus.
- To assess the scientific basis, efficacy, and safety of riboflavin and UV light treatment.
- To identify future research directions for keratoconus management.
Main Methods:
- Review of scientific literature on collagen cross-linking for keratoconus.
- Analysis of existing data on treatment efficacy and long-term safety.
- Evaluation of the mechanism of action of riboflavin and UV light.
Main Results:
- Collagen cross-linking shows promising initial results in treating keratoconus.
- The treatment aims to increase corneal rigidity and slow disease progression.
- Evidence regarding long-term efficacy and safety is still being gathered.
Conclusions:
- Collagen cross-linking represents a significant advancement in keratoconus treatment.
- Further research is needed to fully understand its long-term benefits and risks.
- This treatment has the potential to alter the management of keratoconus patients.
Related Concept Videos
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to form...
Collagens are the Major Structural Proteins of ECM
Connective tissue proper includes loose...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...
